Nu-Med Plus (NUMD) Interest Coverage Ratio Growth (3y) (2015 - 2025)
Nu-Med Plus (NUMD) Interest Coverage Ratio Growth (3y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.30 Bn | 175.00 Bn | 6.27 Bn | -10.66% |
| 2 | Stryker | 128.77 Bn | 125.89 Bn | 3.81 Bn | 61.88% |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn | 46.62% |
| 4 | Boston Scientific | 67.85 Bn | 66.39 Bn | 3.61 Bn | -36.73% |
| 5 | Edwards Lifesciences | 48.12 Bn | 44.45 Bn | 1.29 Bn | -2.41% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 100.22% |
| 7 | GE HealthCare Technologies | 27.98 Bn | 25.70 Bn | 1.98 Bn | 9.28% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.78 Bn | 20.65 Bn | 2.07 Bn | -35.05% |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | -934.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -934.30% |
| Dec 31, 2024 | -414.26% |
| Dec 31, 2023 | 42.27% |
| Sep 30, 2023 | 52.28% |
| Jun 30, 2023 | 56.51% |
| Mar 31, 2023 | 16.91% |
| Dec 31, 2022 | 93.92% |
| Dec 31, 2021 | -26.07% |
| Dec 31, 2020 | -224.62% |
| Sep 30, 2020 | -83.69% |
| Jun 30, 2020 | -126.37% |
| Mar 31, 2020 | -60.50% |
| Dec 31, 2019 | 7.18% |
| Sep 30, 2019 | -31.38% |
| Jun 30, 2019 | 19.74% |
| Mar 31, 2019 | -81.07% |
| Dec 31, 2018 | 21.55% |
| Sep 30, 2018 | 13.03% |
| Jun 30, 2018 | -29.19% |
| Mar 31, 2018 | -1.68% |